Press release
Global Biologics Drug Substance Manufacturing Market to grow at a CAGR of 10.59% to reach USD 968.32 billion by 2032, Evaluates DelveInsight
DelveInsight's "Biologics Drug Substance Manufacturing Market Insights, Competitive Landscape and Market Forecast-2032" report provides the current and forecast market outlook, forthcoming device innovation, challenges, market drivers and barriers. The report also covers the major emerging products and key Biologics Drug Substance Manufacturing companies actively working in the market.
To know more about why North America is leading the market growth in the Biologics Drug Substance Manufacturing market, get a snapshot of the report Biologics Drug Substance Manufacturing Market Trends
https://www.delveinsight.com/sample-request/biologics-drug-substance-manufacturing-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Biologics Drug Substance Manufacturing Overview
Biologics Drug Substance Manufacturing refers to the process of producing the active biological components of a drug, known as the drug substance or active pharmaceutical ingredient (API), which are derived from living cells. Unlike chemically synthesized drugs, biologics include complex molecules such as proteins, antibodies, vaccines, or gene therapies.
DelveInsight Analysis: The biologics drug substance manufacturing market size was valued at USD 436.36 billion in 2024 and is projected to grow at a CAGR of 10.59% from 2025 to 2032, reaching USD 968.32 billion by 2032.
Biologics Drug Substance Manufacturing Market Insights
Geographically, "North America is expected to hold the largest share of the biologics drug substance manufacturing market in 2024. Market growth in the region is primarily driven by the rising number of patients with chronic diseases such as cancer and diabetes. Additionally, an increasing geriatric population, higher R&D activities by key players, and the growing adoption of biologic therapies are contributing to the expansion of the biologics drug substance manufacturing market in North America.
To read more about the latest highlights related to Biologics Drug Substance Manufacturing, get a snapshot of the key highlights entailed in the Biologics Drug Substance Manufacturing Insights
https://www.delveinsight.com/report-store/biologics-drug-substance-manufacturing-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Recent Developments in the Biologics Drug Substance Manufacturing Market Report
• In September 2024, Samsung Biologics launched biologics' innovative development platforms - S-AfuCHOTM and S-OptiChargeTM. S-AfuCHOTM is an innovative cell line platform designed to produce fucosylated antibodies, which demonstrate enhanced antibody-dependent cellular cytotoxicity (ADCC) activity, leading to increased therapeutic efficacy. In parallel, S-OptiChargeTM serves as an upstream process platform capable of modulating a molecule's charge variant distribution.
• In June 2024, Bionova Scientific, a U.S.-based biologics contract development and manufacturing organization (CDMO) within the Asahi Kasei Group, announced plans to establish a new facility in Texas. This expansion aims to enhance its capabilities in biologics manufacturing and support the growing demand for biopharmaceutical products.
• In January 2024, Enzene Biosciences announced the launch of its first manufacturing site in the United States, situated in Hopewell, near Princeton, New Jersey. The company has leased 54,000 square feet of space to accommodate multiple manufacturing lines utilizing its continuous manufacturing technology platform, EnzeneXTM. This facility is designed to integrate Enzene's patented EnzeneXTM platform, allowing for efficient and scalable production of biologics.
• In October 2023, WuXi Biologics announced the launch of its new proprietary bioprocessing platform, WuXiUITM. This ultra-intensified, fed-batch solution is designed to enhance the productivity and quality of various CHO (Chinese Hamster Ovary) and other mammalian cell lines, as well as different product modalities. The WuXiUITM platform significantly improves both productivity and quality while reducing the cost of goods sold (COGS) in commercial manufacturing.
• Thus, owing to such developments in the market, rapid growth will be observed in the Biologics Drug Substance Manufacturing market during the forecast period
Key Players in the Biologics Drug Substance Manufacturing Market
Some of the key market players operating in the Biologics Drug Substance Manufacturing market include- Boston Scientific Corporation, Cook, Rocamed, Accordion Medical, EndoTheia, Inc., KARL STORZ, Olympus Corporation, Coloplast Group, Endotherapeutics Pty Ltd., ELMED Medical Systems, PENTAX Medical, UROMED Kurt Drews KG, BD, Dornier MedTech, NeoScope Inc., OTU Medical, Clarion Medical Technologies, Calyxo, Inc., EMS Urology, Happiness Works Medical, and others.
Which MedTech key players in the Biologics Drug Substance Manufacturing market are set to emerge as the trendsetter explore @ Key Biologics Drug Substance Manufacturing Companies
https://www.delveinsight.com/sample-request/biologics-drug-substance-manufacturing-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Analysis on the Biologics Drug Substance Manufacturing Market Landscape
Leading market players are increasingly investing in innovative technologies to improve monoclonal antibody manufacturing. For example, in April 2024, Evotec Biologics introduced the J.CHOTM high expression system for continuous antibody production. Integrated into Evotec's advanced continuous bioprocessing platform, J.CHOTM enhances both clinical and commercial biologics manufacturing by boosting productivity and maintaining high quality for complex antibody formats, including candidate antibodies, Fc-fusions, and bispecific antibodies.
This advancement is expected to improve manufacturing efficiency and support overall market growth.
Scope of the Biologics Drug Substance Manufacturing Market Report
• Coverage: Global
• Study Period: 2022-2032
• Biologics Drug Substance Manufacturing Market Segmentation By Biologics Type: Monoclonal Antibodies, Recombinant Protein, Growth Hormones, Vaccines, Therapeutic Enzyme, and Others
• Biologics Drug Substance Manufacturing Market Segmentation By Manufacturing: In-house and Outsourced), Production Source (Cell Line/Cell Culture, Genetic Engineering, and Microbial Fermentation
• Biologics Drug Substance Manufacturing Market Segmentation By Geography: North America, Europe, Asia-Pacific, and Rest of the World
• Key Biologics Drug Substance Manufacturing Companies: Boston Scientific Corporation, Cook, Rocamed, Accordion Medical, EndoTheia, Inc., KARL STORZ, Olympus Corporation, Coloplast Group, Endotherapeutics Pty Ltd., ELMED Medical Systems, PENTAX Medical, UROMED Kurt Drews KG, BD, Dornier MedTech, NeoScope Inc., OTU Medical, Clarion Medical Technologies, Calyxo, Inc., EMS Urology, Happiness Works Medical, and others
• Porter's Five Forces Analysis, Product Profiles, Case Studies, KOL's Views, Analyst's View
Interested in knowing how the Biologics Drug Substance Manufacturing market will grow by 2032? Click to get a snapshot of the Biologics Drug Substance Manufacturing Market Analysis
https://www.delveinsight.com/sample-request/biologics-drug-substance-manufacturing-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Contact Us
Gaurav Bora
info@delveinsight.com
+14699457679
www.delveinsight.com
About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing end-to-end comprehensive solutions to improve their performance.
Get hassle-free access to all the healthcare and pharma market research reports through our subscription-based platform PharmDelve.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Biologics Drug Substance Manufacturing Market to grow at a CAGR of 10.59% to reach USD 968.32 billion by 2032, Evaluates DelveInsight here
News-ID: 4264829 • Views: …
More Releases from DelveInsight Business Research
Global Fetal & Neonatal Care Equipment Market to grow at a CAGR of 8.33% to reac …
According to DelveInsight's analysis, The global demand for fetal and neonatal care equipment is largely driven by the rising incidence of preterm births. Additionally, the growing prevalence of congenital anomalies and birth defects, coupled with ongoing technological advancements, is supporting market growth. Continuous product innovations and frequent launches by key players are also contributing to the expansion of the market. These factors are expected to play a crucial role in…
Global Airway Clearance Devices for Cystic Fibrosis Market to grow at a CAGR of …
According to DelveInsight's analysis, The market for airway clearance devices in cystic fibrosis is mainly fueled by the rising prevalence of the disease, an increase in genetic disorder cases, and expanding R&D initiatives. Additionally, collaborative research among key industry players is expected to support the positive growth of the cystic fibrosis airway clearance devices market throughout the forecast period from 2025 to 2032.
DelveInsight's "Airway Clearance Devices for Cystic Fibrosis Market…
Global Total Wrist Prosthesis Market to grow at a CAGR of 4.34% by 2032, Evaluat …
According to DelveInsight's analysis, The global wrist prosthesis market is experiencing substantial growth, driven by the rising prevalence of degenerative bone conditions like rheumatoid arthritis and osteoarthritis, an increase in trauma cases from road accidents, and a higher incidence of sports-related injuries. Additionally, ongoing product development initiatives worldwide are significantly contributing to the market's expansion during the forecast period from 2025 to 2032.
DelveInsight's "Total Wrist Prosthesis Market Insights, Competitive Landscape…
Esophageal Cancer Pipeline 2025: Latest FDA Approvals, Clinical Trials, and Emer …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Esophageal Cancer pipeline constitutes 80+ key companies continuously working towards developing 100+ Esophageal Cancer treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
"Esophageal Cancer Pipeline Insight, 2025" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Esophageal Cancer Market.
The Esophageal…
More Releases for Biologics
Global Biologics Contract Manufacturing Market Set to Reach $83.47 Billion by 20 …
Biologics Contract Manufacturing Market reached US$ 26.03 billion in 2024 and is expected to reach US$ 83.47 billion by 2033, growing at a CAGR of 14.0% during the forecast period 2025-2033.
The Biologics Contract Manufacturing market involves outsourcing the production of complex biologic drugs, including vaccines, antibodies, and recombinant proteins. Rising demand for biologics, cost-effective manufacturing, and scalable production drives growth. Technological advancements in cell culture, purification, and quality control enhance…
Advanced Biologics Manufacturing Solutions Market Future Business Opportunities …
The qualitative latest Research report (2025-2032) on the Advanced Biologics Manufacturing Solutions Market by Coherent Market Insights Provides a deep dive into key market trends, drivers, challenges, and the competitive landscape. It analyzes market size, revenue, production, and CAGR using validated methodologies to ensure precision. The report highlights tech innovation, pricing trends, consumer behavior, and investment potential - empowering businesses to make informed, strategic moves.
Request a Sample Copy: https://www.coherentmarketresearch.com/samplepages/137417
Focused on…
Biologics Fill Finish Manufacturing Market 2024-2031: Global Industry Size, Shar …
According to a new report published by CoherentMI The Biologics Fill Finish Manufacturing Market is estimated to be valued at USD 5.41 Billion in 2024 and is expected to reach USD 9.04 Billion by 2031, growing at a compound annual growth rate (CAGR) of 7.5% from 2024 to 2031.
Most recent Report, named "Biologics Fill Finish Manufacturing Market" Patterns, Offer, Size, Development, Opportunity and Forecast 2024-2031, by CoherentMI offers a…
Biologics Market
The "Biologics Market" is expected to reach USD xx.x billion by 2031, indicating a compound annual growth rate (CAGR) of xx.x percent from 2024 to 2031. The market was valued at USD xx.x billion In 2023.
Growing Demand and Growth Potential in the Global Biologics Market, 2024-2031
Verified Market Research's most recent report, "Biologics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2030," provides an in-depth examination of the industry…
Biologics Contract Manufacturing Market to Witness Huge Growth by 2031 | Wuxi Bi …
The Biologics Contract Manufacturing Market study by DataM Intelligence offer an in-depth analysis of the market, presenting insightful observations, statistics, historical data, and industry-validated market insights. The report delves into the competitive positioning of key companies, examining factors such as product offerings, pricing strategies, financial health, product portfolios, growth initiatives, and geographical reach.
Download a Free sample PDF (Use Corporate email ID to Get Higher Priority) at: - https://datamintelligence.com/download-sample/biologics-contract-manufacturing-market
What is the…
Spine Biologics Market Report 2024 - Spine Biologics Market Trends And Share
"The Business Research Company recently released a comprehensive report on the Global Spine Biologics Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry.
Ready to Dive into Something Exciting? Get Your Free Exclusive Sample…
